Vapogenix Inc.

Vapogenix Inc.

Vapogenix Inc. is a health care startup founded in 2006 and based in the United States. The company focuses on developing a new class of topical, non-opioid analgesics to alleviate pain, treating pain locally at its source. Its products are formulated volatile anesthetics, with the first product being a rapidly acting topical analgesic designed to alleviate pain associated with venipuncture, venous cannulation, and minor dermatological procedures. Vapogenix's approach aligns with the growing need for non-addictive pain relief medications in modern healthcare.

The latest investment was a Venture Round investment on 11 January 2018, and the investor in this round was Kli Capital. This investment demonstrates the confidence of Kli Capital in Vapogenix's innovative approach to pain management and signifies the potential seen in the company's proprietary formulations of volatile anesthetics for localized pain relief.